KBLB (Kraig Biocraft Laboratories) Other Long Term Assets: $0.01 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kraig Biocraft Laboratories Other Long Term Assets?

Kraig Biocraft Laboratories KBLB -0.87% Other Long Term Assets is $0.01 Mil as of Jun. 2026. The stock has 2 warning signs investors should review.

Kraig Biocraft Laboratories's other long-term assets for the quarter that ended in Jun. 2026 was $0.01 Mil.

Kraig Biocraft Laboratories's quarterly other long-term assets increased from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.01 Mil) and increased from Mar. 2026 ($0.01 Mil) to Jun. 2026 ($0.01 Mil).

Kraig Biocraft Laboratories's annual other long-term assets increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.01 Mil) but then declined from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.01 Mil).

Kraig Biocraft Laboratories Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Kraig Biocraft Laboratories's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kraig Biocraft Laboratories Other Long Term Assets Chart

Kraig Biocraft Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.01 0.01

Kraig Biocraft Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Kraig Biocraft Laboratories Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.01 Mil mean?
Kraig Biocraft Laboratories (KBLB) has a Other Long Term Assets of $0.01 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Kraig Biocraft Laboratories and its competitors.
Is Kraig Biocraft Laboratories' Other Long Term Assets too high?
Kraig Biocraft Laboratories' current Other Long Term Assets is $0.01 Mil.
How does Kraig Biocraft Laboratories' Other Long Term Assets compare to NTIC and FSI?
Kraig Biocraft Laboratories' Other Long Term Assets of $0.01 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Chemicals company?
A good Other Long Term Assets depends on the Chemicals industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Kraig Biocraft Laboratories and its competitors. Kraig Biocraft Laboratories's current Other Long Term Assets is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current Other Long Term Assets of $0.01 Mil. The current Other Long Term Assets is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current Other Long Term Assets is $0.01 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kraig Biocraft Laboratories Business Description

Address 2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.